Published on: August 5, 2019
by Traci Pedersen for Psych Central:
A new study has discovered novel connections between liver dysfunction and Alzheimer’s disease (AD).
The findings, published in the journal JAMA Network Open, may lead to earlier detection of Alzheimer’s disease and ultimately better prevention.
With increasing evidence linking Alzheimer’s disease to diabetes or high cholesterol and other systemic illnesses, the research team uncovered a link between liver function and Alzheimer’s, which adds to the understanding of metabolic dysfunction in the disease.
“This is a new paradigm for Alzheimer’s research,” said study leader Kwangsik Nho, Ph.D., radiology professor at Indiana University (IU) School of Medicine.
“Until now, we only focused on the brain. Our research shows that by using blood biomarkers, we can still focus on the brain but also find evidence of Alzheimer’s and improve our understanding of the body’s internal signaling.”
The researchers evaluated more than 1,500 participants from the National Institute of Aging (NIA)-sponsored Alzheimer’s Disease Neuroimaging Initiative (ADNI) for more than two years. They looked at five serum-based liver function assessments, which measure enzymes predominantly found in the liver.
By using biochemical markers, the team was able to uncover evidence of metabolic disturbance and gain a new perspective on altered liver enzymes in association with both cognitive impairment and AD pathophysiology.
The study’s focus outside the brain aligns with known risk factors for Alzheimer’s disease, including metabolic disorders. According to Nho, looking elsewhere in the body for signals correlated with the disease can provide important clues toward detection and ultimately prevention.
“While we have focused for too long on studying the brain in isolation, we now have to study the brain as an organ that is communicating with and connected to other organs that support its function and that can contribute to its dysfunction,” said Rima Kaddurah-Daouk, Ph.D., of Duke University.
“The concept emerges that Alzheimer’s disease might be a systemic disease that affects several organs including the liver.”
The study was a combined effort of the ADNI, a 60-site study, and the Alzheimer’s Disease Metabolomics Consortium (ADMC). Overall, the findings shed new light on the link between the liver and brain. This line of research is expected to ultimately enable physicians to provide more personalized patient care.
“No stone can be left unturned in our attempt to understand the disease and to identify viable therapeutic targets,” said Andrew J. Saykin, Psy.D., director of the Indiana Alzheimer Disease Center at IU School of Medicine and site principal investigator for the Alzheimer’s Disease Metabolomics Consortium.
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.